Muscle Scan Score and Outcomes in Liver Transplant Candidates
Studies a muscle scan score in adults with end stage liver disease awaiting transplant.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Phoenix, United StatesSee the site
- Trial code
- Registry title
- Adverse Outcomes and Mortality in Liver Transplant
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 2 Nov 2022
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional
- Treatments tested
- MAsS
- Record updated
- 5 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with end-stage liver disease who are being checked for a liver transplant and who need an MRI scan as part of that check.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- End-stage liver disease, being evaluated for liver transplantation.
Main reasons for not taking part
- Cannot have an MRI scan (a reason that makes MRI unsafe or not possible)
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- All patients with end-stage liver disease undergoing evaluation for liver transplantation
- Patient clinically indicated for MRI during transplant candidacy evaluation
- Adult
Who cannot take part
- Contra indication to MRI
Where in United States
- Mayo Clinic - ArizonaPhoenix, United StatesContact: Elizabeth Carey, MDTaking people
About the trial
What the trial wants to find out
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
The group in the trial
- Define MAsS cut-point at transplant evaluation to identify those with high risk for adverse outcomesTreatment being tested
Treatment: MAsS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Adverse Outcomes and Mortality in Liver Transplant
- Plain-language title
- Muscle Scan Score and Outcomes in Liver Transplant CandidatesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 August 2026